Regional Plan for Containment of Poliovirus in the Americas. Regional-GAPIII
MetadataShow full item record
[Preface]. In December 2014, WHO published GAPIII: Global Action Plan, for the main purpose of disseminating the global strategy to minimize the risk of reestablishment of circulation of poliovirus from infectious and potentially infectious samples that are stored in facilities in different sectors, including, of course, laboratories. The actions contained in GAPIII are justified in several global decisions that began with the Global Polio Eradication Initiative (GPEI) in May 1988 (WHA41.28 and were updated in the recent “Polio Eradication & Endgame: Strategic Plan (PEESP) 2013-2018.” The strategy to minimize the risk of reestablishing circulation of facility-associated poliovirus described in GAPIII consists of its elimination through the destruction of materials considered to be known or probable sources of the poliovirus, in all but certified, essential facilities and proper biorisk management of these facilities through strict adherence to required safeguards. The reasons for carrying out this task of elimination and assurance of containment in appropriate facilities are based on different scenarios that are explained below. This document seeks to address the actions recommended by the WHO in the GAPIII guide for the containment of both wild and vaccine-derived polioviruses, as well as the PAHO’s interpretation of and recommendations regarding these actions.Note from PAHO Parts of the original text of the WHO GAPIII were eliminated or adapted to align the Regional plan with the recommendations of the small working group that met in April 2015 in Washington, D.C. At its 23rd meeting, the PAHO Technical Advisory Group on Vaccine-preventable Diseases endorsed the proposed Regional Plan for Containment of Poliovirus in the Region of the Americas.
Category of PAHO Strategic Plan 2014-2019
Showing items related by title, author, creator and subject.
Pan American Health Organization (PAHOUnited StatesWashington, D.C, 2016-09)[Executive Summary]. Artemisinin-based combination therapies (ACTs) are the recommended treatments for Plasmodium falciparum malaria in all malaria endemic areas of South America. Resistance of P. falciparum to the ...
External quality control program in infectious diseases screening at laboratories and blood banks in Latin America: an analysis of the past 5 years Mendrone-Junior, Alfredo; Salles, Nanci; Otani, Marcia; Countinho, Adenilson; Alves, Lucas Bassolli de Oliveira; Rocha, Vanderson; Beltrán-Durán, Mauricio (2023-12-08)[ABSTRACT]. Objective. To evaluate the screening of blood samples for infectious disease markers at laboratories and blood banks in Latin America per the findings of an External Quality Assessment Program (EQAP). Methods. ...
Pierre, Russell B.; Fulford, Toni-Anne; Lewis, Kaye; Palmer, Paulette; Walters, Christine; Christie, Celia D.C. (2016-12)Objective. There is a growing body of data that demonstrates increased infectious disease outcomes for HIV-exposed uninfected (HIV-EU) infants as compared to their HIV-unexposed (HU) counterparts. We hypothesized that ...